Collegium Pharmaceutical (COLL) Earnings Date & Reports

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

COLL is expected to report earnings to fall 3.12% to $1.86 per share on November 05

Collegium Pharmaceutical COLL Stock Earnings Reports

Q3'26

Est.

$1.86

Q2'26

Beat

by $0.20

Q1'26

Beat

by $0.13

Q4'25

Missed

by $0.10

Q3'25

Beat

by $0.37

The last earnings report on August 06 showed earnings per share of $1.92, beating the estimate of $1.72. With 556.25K shares outstanding, the current market capitalization sits at 801.19M.

View a ticker or compare two or three

COLL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days